Extending Access to Addiction Treatment Act

Bill 118 HR 3736, also known as the Extending Access to Addiction Treatment Act, aims to expand access to addiction treatment services for individuals struggling with substance abuse disorders. The bill seeks to address the growing opioid epidemic in the United States by increasing the availability of medication-assisted treatment (MAT) for those in need.

One of the key provisions of the bill is the expansion of the Drug Addiction Treatment Act of 2000 (DATA 2000), which allows qualified physicians to prescribe certain medications, such as buprenorphine, to treat opioid addiction. The bill would remove the current cap on the number of patients that a physician can treat with buprenorphine, thereby increasing access to this life-saving medication.

Additionally, the bill would require the Department of Health and Human Services to conduct a study on the barriers to accessing MAT, particularly in rural and underserved areas. This study would help identify ways to improve access to treatment for individuals in these communities. Overall, the Extending Access to Addiction Treatment Act is a bipartisan effort to address the opioid crisis by expanding access to evidence-based treatment options. By removing barriers to MAT and conducting a study on access issues, the bill aims to improve outcomes for individuals struggling with addiction and reduce the devastating impact of the opioid epidemic in the United States.